share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股SEC公告 ·  07/09 16:27
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 07/09/2024, as per the latest SEC filing. These shares, originally acquired on 09/01/2016 as founder's shares in compensation for Borgeson's role, are valued at an aggregate market value of $83,734.73. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of approximately $692,134.77. The upcoming sale represents a continuation of Borgeson's regular divestment of shares in the company.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 07/09/2024, as per the latest SEC filing. These shares, originally acquired on 09/01/2016 as founder's shares in compensation for Borgeson's role, are valued at an aggregate market value of $83,734.73. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of approximately $692,134.77. The upcoming sale represents a continuation of Borgeson's regular divestment of shares in the company.
Recursion Pharmaceuticals, Inc.董事Blake Borgeson計劃於2024年07月09日賣出11,447股A類公司股份,根據最新的SEC文件。這些股份最初是在2016年09月01日獲得的,作爲創始人股份的補償,總市值爲83734.73美元。該計劃中的售賣是在過去三個月發生的一系列交易之後進行的,共出售77289股,總收益約爲692,134.77美元。即將到來的售賣將繼續Borgeson定期減持公司股份的步伐。
Recursion Pharmaceuticals, Inc.董事Blake Borgeson計劃於2024年07月09日賣出11,447股A類公司股份,根據最新的SEC文件。這些股份最初是在2016年09月01日獲得的,作爲創始人股份的補償,總市值爲83734.73美元。該計劃中的售賣是在過去三個月發生的一系列交易之後進行的,共出售77289股,總收益約爲692,134.77美元。即將到來的售賣將繼續Borgeson定期減持公司股份的步伐。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息